Venture Capital and Corporate Venture Capital in Financing Biotech Companies
Regular price
€39.99
14 days return policy
Shipping & Delivery
A01=Stefanie Hochhold
Author_Stefanie Hochhold
Biotech
Category=KJMV1
eq_bestseller
eq_business-finance-law
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
Product details
- ISBN 9783631618745
- Weight: 230g
- Dimensions: 148 x 210mm
- Publication Date: 19 Nov 2011
- Publisher: Peter Lang AG
- Publication City/Country: CH
- Product Form: Paperback
Secure
checkout
Fast Shipping
Easy returns
This book offers insights into three different aspects of financing companies with venture capital (VC) and corporate venture capital (CVC) using three independent and specific datasets. First the study analyses particular VC financing mechanisms depending on differences in the national institutional framework and the experience of the VC investor. The question whether the actual value-adding ability of VC investments in contrast to CVC investments differs from a portfolio company’s perspective is discussed in the second chapter. Finally, the time-dependent performance of CVC investments is analysed.
Stefanie B. Hochhold graduated in Business Administration at Ludwig-Maximilians-University (LMU) in Munich in 2006 and worked as a research and teaching assistant at the Institute of Capital Market Research and Finance at LMU. Since 2009 she holds a Master of Business Research (MBR) and received her PhD degree (Dr. oec. publ.) in 2011.
